Chinese investors are pumping money into US drug startups as Beijing seeks to become a global leader in new medicines, adding to a flood of cash flowing to groundbreaking health firms.
{iframe}http://www.afr.com/business/health/biotechnology/chinese-money-floods-us-biotech-as-beijing-chases-new-cures-20180419-h0yzbu{/iframe}